What Researchers Did
Researchers evaluated the effectiveness of hyperbaric oxygen therapy (HBOT) in reducing symptoms for individuals with postconcussion syndrome.
What They Found
Based on 5 level 1 studies, the authors concluded there is more evidence to refute than support the use of hyperbaric oxygen therapy for postconcussion syndrome. Specifically, four level 1 studies disproved the use of HBOT, while only one level 1 study supported it.
What This Means for Canadian Patients
Canadian patients experiencing persistent postconcussion symptoms should be aware that current evidence largely does not support hyperbaric oxygen therapy as an effective treatment. They should discuss evidence-based treatment options with their healthcare providers, as HBOT may not provide the expected benefits.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this review is that it was based on a synthesis of only five level 1 studies.